Mid Continent Capital’s Novo Nordisk NVO Stock Holding History

Mid Continent Capital’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$2.56M	Buy	94,290 +750	+0.8%	+$21.2K	0.17%	99
2015 Q2	$2.56M	Sell	93,540 -200	-0.2%	-$5.62K	0.14%	118
2015 Q1	$2.5M	Buy	93,740 +8,440	+10%	+$194K	0.14%	124
2014 Q4	$1.8M	Buy	85,300 +850	+1%	+$19K	0.1%	137
2014 Q3	$2.01M	Sell	84,450 -3,800	-4%	-$87.4K	0.12%	131
2014 Q2	$2.04M	Buy	88,250 +38,400	+77%	+$848K	0.12%	135
2014 Q1	$1.14M	Buy	49,850 +5,900	+13%	+$126K	0.07%	171
2013 Q4	$812K	Hold	43,950	–	–	0.05%	190
2013 Q3	$744K	Buy	43,950 +7,000	+19%	+$118K	0.05%	189
2013 Q2	$573K	Buy	+36,950	New	+$615K	0.04%	196

Other funds holding NVO

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Mid Continent Capital's NVO Position: Q3 2015 in Review

Mid Continent Capital increased its Novo Nordisk (NVO) stake by 0.8% in Q3 2015, buying an estimated $21.2K and bringing the position to 94,290 shares worth $2.56M. The position accounts for 0.17% of the portfolio, ranked #99.

Mid Continent Capital first reported a position in NVO in Q2 2013 and has held it in 10 quarters since. The position peaked at $2.56M in Q2 2015. 526 funds tracked by Wall St. Rank hold NVO as of Q3 2015.

Mid Continent Capital held 94,290 shares of Novo Nordisk worth $2.56M as of Q3 2015.
Mid Continent Capital bought 750 Novo Nordisk shares in Q3 2015, an estimated $21.2K.
Novo Nordisk made up 0.17% of Mid Continent Capital's portfolio in Q3 2015, its #99 holding.
Mid Continent Capital first reported a position in Novo Nordisk in Q2 2013 and has held it in 10 quarters since.
Mid Continent Capital's Novo Nordisk position peaked at $2.56M in Q2 2015.
526 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2015.

Based on Mid Continent Capital's 13F filing for Q3 2015, filed 22 Oct 2015.